loading
Research & Development
With incessant passion on R&D, we pursue the new value and differentiated product development.
Home
-
-
R&D Strategy
People-oriented R&D
Regarding R&D, Dongkook Pharmaceutical has reviewed and selected the products with insufficient but high demand medical service to proceed
the differentiated product development targeting the market effectively through strategic marketing.
In addition, in order to react to the change in future healthcare industry initiatively, we have emphasized the development of both the drug
in relation to the improvement of life quality and the product in preparation for aging society and conducted R&D actively.

The core strategy of technical development by the research institute is not only the maintenance and development of existing technology
but also the promotion of a long-term plan to convert the ‘project around the product’ to ‘the project around technology and customers.’
The research institute also has conducted research activities that meet the global trend through the open innovation.
The research institute has put a continuous effort to grow into a research institute that procures global-level research competency
which can give the uniqueness of Dongkook under the R&D slogan of ‘People-oriented Research & Development.’

Strategy for Differentiated Product Development

Our core development strategy centers on two pillars: advancing our existing proprietary technologies and creating new platform technologies. This dual approach not only allows us to expand our product pipeline, but also to incorporate the latest innovations to effectively meet evolving market demands. Through this, we strive to deliver unique, competitive products. To realize this vision, the research institute is continuously building its capabilities to become a world-class R&D group capable of bringing innovative ideas to life.

Market-Driven R&D

At the research institute, we prioritize understanding market needs and developing differentiated products that address unmet demands. Our goal is to enhance patients’ quality of life while aligning our development efforts with trends and requirements in the pharmaceutical industry. We are committed to delivering optimal therapeutic solutions that reflect both clinical value and market expectations.

Growth Through Collaboration

To address global healthcare challenges, we are actively engaging in collaborative research both domestically and internationally. Through open innovation with leading research institutions and industry partners, we are working toward the globalization of our products and reinforcing the strategic value of our research organization.